Anavex Life Sciences Corp (AVXL)

[BakedLangostino]

thank you. will you also please ask about pricing -- I know it seems irrelevant now (this will date me but I am reminded by the famous Jim Mora "playoffs?!" interview line) but all financial models will change drastically if we do not win the appeal and shareholders deserve to know how the company plans to maximize revenue going forward to offset the damage from this rejection. Will they increase the price, or lower it to attract more customers? Or are they just going to take the loss financially? How do they plan to to market this so it can reach the greatest number of patients? Stuff like that but knowing an expected price -- if we can get out of this conference call with just that single piece of information, we can begin to accurately forcast impacts of potential dilution. Without pricing, it's all a guessing game and with enough pressure I think it would help for the public to hear on record just how much cheaper Blarcamesine really is. When the wolves begin howling, the EMA and FDA will listen.

I'm sure you will focus a lot on trial design, the appeals process, and all of that is important -- but this is probably the best opportunity to get some answers from Chris, or at least get him on record, regarding what the plan would have been had CHMP recommended approval last week.

Thanks as always, for your posts here and your service.

- Baked L.